FIRST-EVER EXPERIMENTAL GENE THERAPY SEEKS TO RESTORE VISION BY REJUVENATING EYE NEURONS

Summary from the TLDR newsletter

ER-100 is an experimental gene therapy designed to restore vision by reviving damaged neurons in the eye. The approach resets aged retinal cells to a healthier state using epigenetic reprogramming. It received FDA approval for human trials last week. If successful, ER-100 could signal a broader shift in how age-related diseases are treated.